Innovative Tongue Test Promises Faster Detection of Influenza

A novel taste-based molecular sensor using thyme flavor detection offers a quick and accessible method for early influenza diagnosis, with potential for at-home screening and pre-symptomatic detection.
As flu season approaches in the northern hemisphere, scientists are exploring novel methods for early detection to curb the spread of the virus. A recent breakthrough involves using a simple taste-based test that could replace traditional nasal swabs with a chewing gum or lozenge. This innovative approach employs a molecular sensor designed to release a distinctive thyme flavor—detected by the human tongue—when it encounters the influenza virus.
Researchers from the American Chemical Society have developed this low-tech sensor targeting the viral enzyme neuraminidase, which influenza viruses use to infect host cells. By attaching thymol, the compound responsible for thyme's herbal flavor, to a neuraminidase substrate, the sensor releases the flavor molecules when the virus is present. This interaction causes the taste of thymol to be detected instantly on the tongue, indicating a possible infection.
Laboratory tests using saliva from infected individuals demonstrated that the sensor releases thymol within 30 minutes without affecting cell health or function. The team envisions incorporating this sensor into everyday items like chewing gum or lozenges, allowing for accessible at-home screening. Such a diagnostic tool could be especially valuable because traditional tests, such as nasal swabs, although accurate, are often slow and costly, and current rapid tests may not identify pre-symptomatic infections.
The researchers aim to start human clinical trials within two years to validate the sensor’s effectiveness in detecting influenza in people before symptoms appear. If successful, this flavor-based detection method could serve as a quick, simple, and widely available first-line screening tool, particularly useful in high-risk environments. The technology is currently under patent review, marking an exciting step forward in infectious disease diagnostics.
This approach offers a promising alternative to existing testing methods, potentially helping to prevent the silent spread of influenza and other viral illnesses by enabling early, easy detection.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Molecular Mapping Technique Revolutionizes Heart Disease Research
A new molecular mapping method developed by researchers at the University of Copenhagen provides detailed insights into the causes of heart diseases, paving the way for targeted treatments and improved diagnostics.
Concerns Rise as Vaccine Experts Criticized by U.S. Health Leadership
Vaccine experts who were recently dismissed by the U.S. Department of Health and Human Services warn that recent leadership changes threaten decades of immunization progress and public health safety.
Understanding How SARS-CoV-2 Continues to Evolve: Insights from Long-Term Lab Research
Recent long-term studies reveal SARS-CoV-2's remarkable ability to mutate, with recurring changes that can predict future variants and inform vaccine development.
Innovative Self-powered Patch Tracks Biomarkers Non-invasively
A novel self-powered microneedle patch can non-invasively monitor health biomarkers by collecting dermal interstitial fluid, eliminating the need for blood draws and external power sources.



